Flordeliz (Gigi) Osler

Market access for beef and cattle, achieving new and defending existing trade agreements. research into blockchain technology in traceability programs, Business risk management programs, Livestock Tax Deferral, Livestock Price Insurance, Agristability, Animal Health programs. Regulations and legislation related to beef cattle and meat production, exports and imports. Farm policy and programs with respect to business risk management, innovation, environment, etc. "Taxation policies and programs related to farm income, capital gains, generational transfer of assets, family income sharing, investment income, and tax deferrals for extraordinary revenue due to inventory liquidation during a declared disaster."

research into blockchain technology in traceability programs, Business risk management programs, Livestock Tax Deferral, Livestock Price Insurance, Agristability, Animal Health programs. Regulations and legislation related to beef cattle and meat production, exports and imports. Market access for beef and cattle, achieving new and defending existing trade agreements. Farm policy and programs with respect to business risk management, innovation, environment, etc. "Taxation policies and programs related to farm income, capital gains, generational transfer of assets, family income sharing, investment income, and tax deferrals for extraordinary revenue due to inventory liquidation during a declared disaster."

International trade regarding tobacco control, alcohol, products containing carcinogens and products associated with cancer. Internal trade regarding tobacco control, alcohol, products containing carcinogens and products associated with cancer. Funding for programs to be operated by the Canadian Cancer Society to advance cancer control. Canadian Partnership Against Cancer, as it relates to continued federal funding for the cancer control strategy Canada Health Transfer and health system bilateral funding agreements intended for provinces/territories to support the delivery of healthcare services Framework Convention on Tobacco Control, including protocols, guidelines and implementation Tobacco and Vaping Products Act, as it relates to regulations, implementation and enforcement Non-Smokers' Health Act including implementation and enforcement Food and Drugs Act and regulations, as it relates to nciotine replacement products Federal Tobacco Control Strategy, including all matters related to tobacco control Taxation, revenue measures, controlled products regulations, including implementation, for alcohol, tobacco control, products containing carcinogens and products associated with cancer. Communication regarding alcohol consumption guidance. Food and Drugs Act and regulations, as it relates to alcohol warning labels Food and Drugs Act and regulations, as it relates to restricting the advertising to children of foods high in sodium, sugars and saturated fat. Healthy Living - Supporting initiatives, legislation, regulation, policies, and programs that prevent cancer or improve the social determinants of health Adoption of HPV testing and increasing HPV vaccination rates Sustainable funding of the National Advisory Committee on Preventive Health Services to ensure timely, up?to?date cancer screening guidelines Equitable and timely access to cancer screening. Measures and funding related to the charitable sector generally Equitable access to care along the full cancer continuum for First Nations, Inuit and Métis communities Employment Insurance special benefit programs, including the sickness benefit and compassionate care benefit Canada Labour Code and Employment Insurance Act, as it relates to job-protected leave, employment insurance special benefits, return to work policies, and human rights protections for people affected by cancer Access to information and support to make decisions regarding end-of-life care, including Medical Assistance In Dying Supports for mental health during people's cancer journeys Implementation and funding of the National Grief Action Plan as part of the government's work on palliative care and mental health Canada Health Act as it relates to access to care, including long-term, home, and palliative care National Caregiving Strategy Financial supports for caregivers, including the Canada Caregiver Credit Implementation of the Framework on Palliative Care in Canada and integration of a palliative approach to care in our health system, including national standards and data, care provider training, research, and implementation of the National Grief Action Plan and distinctions?based frameworks for First Nations, Inuit and Métis people Setting and measuring pan-Canadian wait time benchmarks and targets and measures to address them, including addressing healthcare shortages, increased and sustainable funding for care, infrastructure and equipment, targeted strategic funding to PTs for workforce shortages, particularly in rural and remote communities. Sustained core funding for federal research agencies, improved coverage of indirect research costs, Canadian research sovereignty, strengthening capacity and the economic benefits of domestic research, research commercialization. Increasing access to care including models of care, removing barriers to care, particularly for underserved communities, using innovative approaches to improve access to care including AI to improve timely diagnosis and treatment. Issu

INDIGENOUS HEALTH: Improvement to the health and health care services provided to Indigenous peoples in Canada including adding inclusive lettering on health cards across Canada. Advocating for the creation of a national Chief Health Accountability Officer. TECHNOLOGY AND ARTIFICIAL INTELLIGENCE: provide CMA’s perspective on the impact of technology and artificial intelligence on the health care sector including input on Bill C-27, and the means through which advancements can be foreseen and managed. PUBLIC-PRIVATE HEALTHCARE: The CMA is conducting a series of in-person sessions across the country to engage key stakeholders, including the public, physicians, patients/PWLE, policymakers, system leaders and others, in a dialogue on public-private healthcare. What we hear will inform CMA policy moving forward, and our recommendations for action at a national level. PHYSICIAN PARLIAMENTARIAN CAUCUS: advocate for the formation of a Physician Parliamentarian Caucus as a means of examining deficiencies in the health care system and proposing solutions. PHYSICAL, PSYCHOLOGICAL AND CULTURAL SAFETY: Advocate to address the challenges and opportunities for physical, psychological and cultural safety within Canada’s health system, including the implementation of a nation-wide anti-racism plan, the creation of a Canada Mental Health transfer, improving access to mental health services to physicians and their families, gender-affirming care, creating an emergency National Mental Health Support Services hotline for all health care providers, the creation of a National Physicians Day in Canada, ensuring safe and unimpeded access to health care facilities for health care workers and patients. PERSONAL INFORMATION PROTECTION AND ELECTRONIC DOCUMENT ACT (PIPEDA) PRIVACY PROTECTION OF HEALTH INFORMATION AND THE REGULATORY REVIEW: Improvement to privacy legislation to protect the privacy of health information. PAN CANADIAN LICENSURE: Advocate for the ability for physicians with full licences to practise independently without restrictions or for medical resident trainees registered in any Canadian jurisdiction to practise or train in any other Canadian jurisdiction without having to acquire more than one licence or pay additional licensing fees. This includes exploring enabling legislation in the provinces and territories. NET ZERO: Advocate for sustainable health systems in Canada, including reaching net-zero emissions by 2050; advocate for the establishment of a national climate and health secretariat within the federal government to develop a pan-Canadian approach to addressing the impacts of climate change and health; and advocate for a targeted health infrastructure fund as part of the federal government’s long-term plan for public infrastructure. MEDICAL ASSISTANCE IN DYING: Advancing the medical profession’s perspectives on medical assistance in dying. INTEGRATED HEALTH HUMAN RESOURCES Advocate for an Integrated Health Human Resources Strategy, including creating retention incentives and addressing administrative burden for health care professionals, increasing the number of doctors and nurses and ensuring that every Canadian has access to a family doctor or primary health team, increasing access to virtual care, creating an action plan to get internationally trained health care professionals to work, improving workforce data collection across health systems and investing in a supply needs-based planning tool, and facilitating team-based health care. INDIGENOUS HEALTH AND RECONCILIATION WITH INDIGENOUS PEOPLES: Implementation of the Calls to Action of the Truth and Reconciliation Commission, including addressing the ongoing structural inequities that marginalize Indigenous Peoples, advancing the inclusion of Indigenous Peoples in societal systems and sectors, including health systems, and committing to collaborative and respectful relationships with Indigenous patients and communities. The CMA is also advocating to increase trust between Ind

Communicating with government officials about the proposed Safe Social Media Act (Bill C-34) as it relates to reducing the harms to children and their access to online content. Communicating with government officials about artificial intelligence (AI), including about (i) the potential regulation of AI by government, (ii) potential uses for AI in government, (iii) investments in AI by government, including via the AI Compute Access Fund, (iv) technological developments related to AI, (v) the promotion of AI literacy, training and skills development and (vi) the development, implementation and amendment of AI policies, including but not limited to the “Canadian Guardrails for Generative AI – Code of Practice”, the “Voluntary Code of Conduct on the Responsible Development and Management of Advanced Generative AI Systems” and the “Canadian AI Sovereign Compute Strategy. Communicating with government officials about the Online Harms Act (formerly Bill C-63), more specifically about the regulation of online content. Communicating with government officials about the Digital Charter Implementation Act, 2022 (formerly Bill C-27), more specifically the creation of the Consumer Privacy Protection Act, the Personal Information and Data Protection Tribunal Act, and the Artificial Intelligence and Data Act. Communicating with government officials about the proposed Supporting Authorized Access to Information Act (Bill C-22) as it relates to the timely production of data and information. Communicating with government officials about the proposed Protecting Victims Act (Bill C-16) as it relates to youth safety online. Communicating with government officials, in general, about opportunities and challenges facing the creator economy, including as it relates to skills training, content creation and economic conditions. Communicating with government officials about the design and implementation of the National Anti-Fraud Strategy (announced in November 2025). Communicating with government officials about Bill S-209 (“An Act to restrict young persons’ online access to pornographic material”), including as it relates to the enactment of the Protecting Young Persons from Exposure to Pornography Act. Communicating with government officials about Bill C-8 (“An Act respecting cyber security, amending the Telecommunications Act and making consequential amendments to other Acts”), including as it relates to the amendment of the Telecommunications Act, S.C. 1993, c. 38, and the enactment of Critical Cyber Systems Protection Act. Communicating with government officials about industry and government efforts to promote online safety including but not limited to (i) combatting misinformation and disinformation, (ii) ensuring child safety, (iii) reducing online scams and fraudulent activity, (iv) minimizing online spam and (v) removing harmful online content. Communicating with government officials about proposed and existing youth privacy and age assurance measures, including the potential establishment of a youth privacy code. These communications may touch on, but are not limited to, the consultation launched by the Office of the Privacy Commissioner of Canada. Communicating with government officials about existing and proposed credit counselling regulations under the Financial Consumer Agency of Canada Act, S.C. 2001, c. 9 and the Bank Act, S.C. 1991, c. 46. Communicating with government officials, in general, about digital sovereignty. Communicating with government officials about "An Act to restrict young persons’ online access to sexually explicit material" (formerly in Bill S-210). Communicating with government officials about "An Act to enact the Protection of Minors in the Digital Age Act and to amend the Criminal Code" (formerly Bill C-412), more specifically about the regulation of online content. Communicating with government officials about "An Act respecting the interoperability of health information technology and to prohibit data blocking by

World Trade Organization (WTO) issues concerning the agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPs) with respect to the protection of data, Access to Medicines, and TRIPs "flexibility" World Intellectual Property Organization (WIPO) issues concerning the protection of and access to intellectual property World Health Organization (WHO) issues concerning pharmaceuticals as it relates to Counterfeits, Access to Medicines, and the Intergovernmental Working Group (IGWG) The government's Science and Technology strategy as it relates to the biopharmaceutical industry Subsequent Entry Biologics (SEBs) as it relates to Regulations, Policies, or Guidelines being developed by Health Canada, specifically the Draft Guidance Document on SEBs, the Notices of Changes to Health Canada's Guidance Documents on Data Protection and Patented Medicines Regulations (Notice of Compliance) Regulations Smart Regulations as it relates to the biopharmaceutical industry Scientific Research and Educational Design (SR&ED) Tax Credit in respect of updating the system and increasing the expenditure limit for refundable credits Pharmaceutical pricing policy issues arising from the jurisdiction of the Patended Medicines Prices Review Board (PMPRB) Patented Medicines Regulations as it relates to the regulation and protection of biopharmaceutical products Patented Medicines (Notice of Compliance) Regulations with respect to ensuring that patent rights are respected and are internationally competitive Patented Medicines (Notice of Compliance) Regulations as it relates to the regulation of intellectual property for biopharmaceutical products Patent Act as it relates to reporting requirements and pricing guidelines, and the protection of intellectual property in biopharmaceutical products New Substances Notification Regulations as it relates to the biopharmaceutical industry Income Tax Act as it relates to biopharmaceutical products Health Canada’s Interim Orders relating to COVID-19: The Interim Order Respecting Drugs, Medical Devices and Foods for a Special Dietary Purpose in Relation to COVID-19; The Interim Order Respecting Clinical Trials for Medical Devices and Drugs Relating to COVID-19; The Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19; The Interim Order Respecting the Prevention and Alleviation of Shortages of Drugs in Relation to Covid-19 Health Canada's Regulatory Roadmap for Health Products and Food as it relates to the biopharmaceutical industry Free trade treaty agreement as they relate to the North American Free Trade Agreement (NAFTA) and free trade negotiations as it relates to India, the European Union, Japan, MERCOSUR and the Trans-Pacific Partnership Food and Drugs Act and Regulations and the Import and Export Permits Act with respect to cross-border trade as it relates to the export of Canadian biopharmaceuticals Food and Drug Regulations as it relates to data protection and the regulation and protection of biopharmaceutical products Establish accountability with the federally financed Canadian Agency for Drugs and Technologies in Health (CADTH) Common Drug Review Policies as it relates to reimbursement recommendation decision-making process and framework Canadian Institutes of Health Research (CIHR) Clinical Research Initiative as it relates to public/private research and development partnerships Canadian Environmental Protection Act and Regulations in respect of modern, science-based regulations to reflect rapidly changing new technologies Canada-United States Regulatory Cooperation Council (RCC) initiatives related to the regulation of biopharmaceutical products Canada's Food and Consumer Safety Action Plan as it relates to the regulation and protection of biopharmaceutical products Canada's Access to Medicines Regime with respect to ensuring that the program allows for the delivery of timely access to needed medicines to the developing world supported by a b

Research Canada is a collaborative advocacy leader working to achieve policy impact by strengthening political and public support for a robust health research and innovation ecosystem in Canada.

Working with federal partners to streamline Health Canada policies and processes related to clinical trials and drug authorization specific to children, including the passage of C-265, an Act to Amend the Food and Drugs Act. Supporting the introduction and passing of legislation that would increase protections for children and youth online, including the passage of C-34, the Safe Social Media Act. Encouraging the development and strengthening of legislation and regulations that limit children's access to nicotine. Engaging federal partners on the national and international role that SickKids plays in child health care, research and education.